Trial record 9 of 13 for:    "Epilepsy Juvenile Absence"

Magnetoencephalography in Absence Seizures

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00884351
First received: April 17, 2009
Last updated: June 16, 2011
Last verified: June 2011
  Purpose

Background:

  • An absence seizure is a type of seizure that usually begins in childhood and goes away by early adulthood. Scientists do not yet know where absence seizures begin in the brain. Some evidence suggests that these seizures begin in the thalamus, a structure deep in the brain, but other studies suggest that they begin in the frontal cortex, at the front part of the brain.
  • Magnetoencephalography is a type of brain scanning procedure that is useful in determining information about what happens to the brain during epileptic seizures. Understanding where absence seizures come from may help doctors find new treatments for them.

Objectives:

  • To gain a better understanding of which parts of the brain are affected in absence seizures.

Eligibility:

  • Patients 7 to 35 years of age who have been diagnosed with absence seizures.

Design:

  • Procedures are for research purposes only, not to diagnose or treat a particular medical condition.
  • Two outpatient visits to the National Institutes of Health Clinical Center: evaluation and scanning.
  • Researchers will evaluate potential participants with a medical history, physical examination, and electroencephalography (EEG). These tests will be performed under another protocol, 01-N-0139.
  • Patients will undergo magnetoencephalography (MEG) and magnetic resonance imaging (MRI) of the brain. The study procedures will be performed one time; however, an MEG or MRI scan may need to be repeated for technical reasons. Researchers will not do more than two MEG or MRI scans.
  • The MEG will record very small magnetic field changes produced by the activity of the brain. An EEG will be recorded at the same time as the MEG.
  • The MRI will use a magnetic field to take pictures of the inside of the brain.
  • The MEG will take 3 hours to complete (2 hours for preparation, 1 hour in the scanner). The MRI will take approximately 1 hour.

Condition
Seizures

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Magnetoencephalography in Absence Seizures

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Enrollment: 5
Study Start Date: April 2009
Estimated Study Completion Date: June 2011
Detailed Description:

Objective:

This protocol will test the hypothesis that the 3-Hz spike-wave discharges seen in absence epilepsy originate in the thalamus. We will use an emerging modality, magnetoencephalograpy (MEG), to test this hypothesis.

Study Population:

33 patients with absence seizures.

Design:

This is a non-invasive imaging study that involves a 275-channel whole head MEG recording and a structural MRI for co-registration of MEG data.

Outcome Measure:

The primary outcome measure is the source localization of spike-wave discharges on magnetoencephalography.

  Eligibility

Ages Eligible for Study:   7 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

    1. Age 7-35
    2. Absence of seizures based on clinical and electroenecephalography data. Patients who have other seizure types (myoclonic, generalized tonic-clonic) in addition to absence seizures may be included.
    3. Patients who have other neurologic disorders may be included, as long as they are able to consent/assent.

EXCLUSION CRITERIA:

  1. Contraindications to MEG studies (Dental braces, permanent retainers, metal dental caps/crowns/fillings)
  2. Contraindications to MRI studies (such as pacemakers, cochlear devices, surgical clips, metallic implants, orthopedic pins, shrapnel, permanent eyeliner, vagus nerve stimulator)
  3. Claustrophobia or anxiety disorders exacerbated by MRI
  4. Pregnancy
  5. Inability to provide consent/assent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00884351

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00884351     History of Changes
Other Study ID Numbers: 090125, 09-N-0125
Study First Received: April 17, 2009
Last Updated: June 16, 2011
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Epilepsy
MEG
Seizures

Additional relevant MeSH terms:
Epilepsy, Absence
Seizures
Epilepsy, Generalized
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on July 20, 2014